167 related articles for article (PubMed ID: 37598062)
1. Cardiogenic shock in adults with congenital heart disease: Insights from the FRENSHOCK registry.
Karsenty C; Touafchia A; Ladouceur M; Roubille F; Bonnefoy E; Bonello L; Leurent G; Levy B; Champion S; Lim P; Schneider F; Cariou A; Khachab H; Bourenne J; Seronde MF; Harbaoui B; Vanzetto G; Quentin C; Delabranche X; Combaret N; Morel O; Lattuca B; Leborgne L; Fillippi E; Gerbaud E; Brusq C; Bongard V; Lamblin N; Puymirat E; Delmas C;
Arch Cardiovasc Dis; 2023; 116(8-9):390-396. PubMed ID: 37598062
[TBL] [Abstract][Full Text] [Related]
2. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).
VanderPluym CJ; Cedars A; Eghtesady P; Maxwell BG; Gelow JM; Burchill LJ; Maltais S; Koehl DA; Cantor RS; Blume ED
J Heart Lung Transplant; 2018 Jan; 37(1):89-99. PubMed ID: 28365175
[TBL] [Abstract][Full Text] [Related]
3. Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
Shinkawa T; Ichihara Y; Saito S; Ishido M; Inai K; Niinami H
J Cardiol; 2023 Apr; 81(4):378-384. PubMed ID: 36152979
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with temporary right ventricular mechanical circulatory support.
Bhama JK; Bansal U; Winger DG; Teuteberg JJ; Bermudez C; Kormos RL; Bansal A
J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1885-1891. PubMed ID: 29861112
[TBL] [Abstract][Full Text] [Related]
5. An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease.
Cedars A; Vanderpluym C; Koehl D; Cantor R; Kutty S; Kirklin JK
J Heart Lung Transplant; 2018 May; 37(5):619-630. PubMed ID: 29198868
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal Life Support for Cardiogenic Shock in Adult Congenital Heart Disease-An ELSO Registry Analysis.
Rali AS; Garry JD; Dieter RA; Schlendorf KH; Bacchetta MD; Zalawadiya SK; Mishra K; Trahanas J; Frischhertz BP; Lindenfeld J; Olson TL; Cedars AM; Anders MM; Tonna JE; Dolgner SJ; Alvis BD; Menachem JN
ASAIO J; 2023 Nov; 69(11):984-992. PubMed ID: 37549669
[TBL] [Abstract][Full Text] [Related]
7. Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry.
Manzo-Silberman S; Martin AC; Boissier F; Hauw-Berlemont C; Aissaoui N; Lamblin N; Roubille F; Bonnefoy E; Bonello L; Elbaz M; Schurtz G; Morel O; Leurent G; Levy B; Jouve B; Harbaoui B; Vanzetto G; Combaret N; Lattucca B; Champion S; Lim P; Bruel C; Schneider F; Seronde MF; Bataille V; Gerbaud E; Puymirat E; Delmas C;
J Crit Care; 2024 Aug; 82():154785. PubMed ID: 38493531
[TBL] [Abstract][Full Text] [Related]
8. UNOS listing status-related changes in mechanical circulatory support utilization and outcomes in adult congenital heart disease patients.
Zhou AL; Menachem JN; Danford DA; Kutty S; Cedars AM
J Heart Lung Transplant; 2022 Jul; 41(7):889-895. PubMed ID: 35397877
[TBL] [Abstract][Full Text] [Related]
9. Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
Cherbi M; Bouisset F; Bonnefoy E; Lamblin N; Gerbaud E; Bonello L; Levy B; Lim P; Joffre J; Beuzelin M; Roland Y; Niquet L; Favory R; Khachab H; Harbaoui B; Vanzetto G; Combaret N; Marchandot B; Lattuca B; Leurent G; Lairez O; Puymirat E; Roubille F; Delmas C
Int J Cardiol; 2024 Jan; 395():131578. PubMed ID: 37956759
[TBL] [Abstract][Full Text] [Related]
10. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
[TBL] [Abstract][Full Text] [Related]
11. Impact of durable ventricular assist devices on post-transplant outcomes in adults with congenital heart disease.
Cedars A; Burchill L; Roche SL; Menachem J; Axsom K; Tecson K;
Congenit Heart Dis; 2019 Nov; 14(6):958-962. PubMed ID: 31625684
[TBL] [Abstract][Full Text] [Related]
12. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
[TBL] [Abstract][Full Text] [Related]
13. Heart transplantation with or without prior mechanical circulatory support in adults with congenital heart disease.
Maxwell BG; Wong JK; Sheikh AY; Lee PH; Lobato RL
Eur J Cardiothorac Surg; 2014 May; 45(5):842-6. PubMed ID: 24135956
[TBL] [Abstract][Full Text] [Related]
14. Bridge to durable left ventricular assist device for refractory cardiogenic shock.
Yoshioka D; Takayama H; Garan AR; Topkara VK; Han J; Li B; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
J Thorac Cardiovasc Surg; 2017 Apr; 153(4):752-762.e5. PubMed ID: 27988030
[TBL] [Abstract][Full Text] [Related]
15. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes.
Takayama H; Soni L; Kalesan B; Truby LK; Ota T; Cedola S; Khalpey Z; Uriel N; Colombo P; Mancini DM; Jorde UP; Naka Y
Circ Heart Fail; 2014 Sep; 7(5):799-806. PubMed ID: 25027874
[TBL] [Abstract][Full Text] [Related]
16. "Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry.
Saad M; Fuernau G; Desch S; Eitel I; Jung C; Pöss J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H
Int J Cardiol; 2016 Nov; 222():775-779. PubMed ID: 27521557
[TBL] [Abstract][Full Text] [Related]
17. PRospective REgistry of PAtients in REfractory cardiogenic shock-The PREPARE CardShock registry.
von Lewinski D; Herold L; Stoffel C; Pätzold S; Fruhwald F; Altmanninger-Sock S; Kolesnik E; Wallner M; Rainer P; Bugger H; Verheyen N; Rohrer U; Manninger-Wünscher M; Scherr D; Renz D; Yates A; Zirlik A; Toth GG
Catheter Cardiovasc Interv; 2022 Sep; 100(3):319-327. PubMed ID: 35830719
[TBL] [Abstract][Full Text] [Related]
18. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
[TBL] [Abstract][Full Text] [Related]
19. Prioritising transplantation for adult congenital heart disease, UK national data.
Burch M; Taylor A; Mehew J; Dominguez T; Crossland D; Lewis C; Taylor R; Clift P; Al-Attar N; Venkateswaran R; Banner N
Int J Cardiol; 2020 May; 307():36-40. PubMed ID: 31604656
[TBL] [Abstract][Full Text] [Related]
20. Impella CP use in patients with non-ischaemic cardiogenic shock.
Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
